IP Library Granted Patent US 7,333,852
Granted Patent B2
US 7,333,852 · App. 10/204,334 · Granted Feb 19, 2008

Method and apparatus for destroying dividing cells

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,333,852
App. No.
10/204,334
Granted
Feb 19, 2008
Kind
B2
Abstract

The present invention provides a method and apparatus for selectively destroying dividing cells in living tissue formed of dividing cells and non-dividing cells. The dividing cells contain polarizable intracellular members and during late anaphase or telophase, the dividing cells are connected to one another by a cleavage furrow. According to the present method the living tissue is subjected to electric field conditions sufficient to cause movement of the polarizable intracellular members toward the cleavage furrow in response to a non-homogenous electric field being induced in the dividing cells. The non-homogenous electric field produces an increased density electric field in the region of the cleavage furrow. The movement of the polarizable intracellular members towards the cleavage furrow causes the break down thereof which results in destruction of the dividing cells, while the non-dividing cells of the living tissue remain intact.

Claims (36)

1. A method for selectively destroying dividing cells in living tissue, the dividing cells having polarizable intracellular members, the method comprising the steps of:

passing a first electric field through the living tissue to produce a non-homogenous electric field within the dividing cells with an increased density in a region of a cleavage furrow in late anaphase or telophase, the non-homogenous electric field being sufficient to move the polarizable intracellular members toward the cleavage furrow until the intracellular members disrupt the cleavage furrow, wherein the passing step is implemented for one or more intervals of time that are collectively sufficient for the disruptions of the cleavage furrow to destroy a significant portion of the dividing cells in the living tissue, and wherein passage of the first electric field through nondividing cells in the living tissue leaves the nondividing cells substantially undamaged.

2. A method according to claim 1 , wherein the cleavage furrow is in the form of a cytoplasm bridge membrane.

3. A method according to claim 1 , wherein the first electric field has a sufficient frequency so that the non-homogenous electric field produced in the dividing cells defines electric field lines which generally converge at a region of the cleavage furrow, thereby defining the increased density electric field.

4. A method according to claim 1 , wherein the passing step comprises the step of:

subjecting the living tissue to an alternating electric potential at a sufficient frequency to cause associated electric field lines to penetrate the dividing cells and form the non-homogenous electric field within the dividing cells.

5. A method according to claim 1 , wherein the non-homogenous electric field

generates electric forces in the dividing cells which act to pull the polarizable intracellular members toward the increased density electric field region.

6. A method according to claim 1 , wherein the polarizable intracellular members are organelles.

7. A method according to claim 1 , wherein the passing step comprises the step of:

subjecting the living tissue to a pulsating alternating electric potential at a sufficient frequency to form the non-homogenous electric field within the dividing cells.

8. A method according to claim 1 , wherein the passing step comprises the step of:

subjecting the living tissue to an alternating electric potential at a frequency of between about 10 kHz and about 1 MHz.

9. A method according to claim 1 , wherein the dividing cells comprise a first sub-cell and a second sub-cell with the cleavage furrow connecting the two in late anaphase or telophase.

10. A method according to claim 1 , wherein the passing step comprises the step of:

providing a first electrode;

providing a second electrode;

applying an alternating electric potential across the first and second electrodes, wherein the first and second electrodes are disposed in a vicinity of the living tissue to be treated.

11. A method according to claim 1 further comprising the step of:

rotating a source of the first electric field relative to the living tissue.

12. A method according to claim 1 , wherein movement of the intracellular members toward the cleavage furrow increases pressure being exerted on the cleavage furrow, the increased pressure causing the region of the cleavage furrow to expand resulting in the cleavage furrow breaking apart and causing destruction of the dividing cells.

13. A method according to claim 1 , wherein the living tissue is subjected to the first electric field for a predetermined period of time.

14. A method according to claim 13 , wherein the predetermined period of time is less than about 2 hours.

15. A method according to claim 1 , further comprising:

removing the first electric field for a predetermined period of time; and

resubjecting the living tissue to the first electric field after the predetermined period of time has passed.

16. A method according to claim 1 , wherein the first electric field is a substantially uniform electric field.

17. A method according to claim 1 , wherein the passing step is continued for one or more intervals of time that collectively comprise at least two hours.

18. A method for selectively destroying dividing cells in living tissue, the dividing cells containing polarizable intracellular members, the method comprising the step of:

passing an electric field through the living tissue to create conditions in dividing cells in late anaphase or telophase which are sufficient to cause displacement of the polarizable intracellular members towards a cleavage furrow connecting the dividing cells in response to a non-homogenous electric field being induced in the dividing cells, wherein the passing step is continued for one or more intervals of time that are collectively sufficient to permit the displacement of the polarizable intracellular members to cause a break down of the cleavage furrow which results in the destruction of a significant portion of the dividing cells while non-dividing cells of the living tissue remain intact.

19. A method according to claim 18 , wherein the passing step comprises the step of:

subjecting the living tissue to an alternating electric potential at a frequency of between about 10 kHz and about 1 MHz.

20. A method according to claim 18 , wherein the passing step is continued for one or more intervals of time that collectively comprise at least two hours.

21. A method for selectively destroying a dividing-cell organism, the organism containing polarizable intracellular members and being attached to one another in late anaphase or telophase with a cleavage furrow, the method comprising the step of:

passing an electric field through the organism to create electric field conditions sufficient to cause displacement of the polarizable intracellular members towards the cleavage furrow in response to a non-homogenous electric field being induced in the organism, wherein the electric field conditions are applied for one or more intervals of time that are collectively sufficient to permit the non-homogenous electric field produced within the dividing cells to cause the displacement of the polarizable intracellular members, to cause a break down of the cleavage furrow which results in destruction of the dividing organism.

22. A method according to claim 21 , wherein the passing step is continued for one or more intervals of time that collectively comprise at least two hours.

Assignments (12)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
CHANGE OF NAME Recorded May 19, 2011
From: STANDEN LIMITED
To: NOVOCURE LIMITED
Reel/Frame 026311/0210 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2003
From: PALTI, YORAM
To: STANDEN LTD.
Reel/Frame 014214/0072 →